Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000992287 | SCV001144465 | uncertain significance | not provided | 2019-03-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001858747 | SCV002201192 | uncertain significance | Autosomal dominant Parkinson disease 8 | 2025-01-03 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 924 of the LRRK2 protein (p.Arg924His). This variant is present in population databases (rs200795874, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with LRRK2-related conditions. ClinVar contains an entry for this variant (Variation ID: 804995). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt LRRK2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV001858747 | SCV002786194 | uncertain significance | Autosomal dominant Parkinson disease 8 | 2021-09-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000992287 | SCV004130549 | likely benign | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing | LRRK2: BP4, BS2 |